Physician profile
Colleen M Dzikowski
NPI 1659368892
$2,856.03
in general payments reported to CMS, 2019-2025
22 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2021: $225 · 2022: $387 · 2023: $469 · 2024: $632 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $786.01 | 2021-2025 | Nuzyra |
| Smith+Nephew, INC. | $407.39 | 2019-2025 | Grafix Pl, Stravix Pl, Oasis Micro |
| Integra Lifesciences Corporation | $307.11 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Wright Medical Technology, INC. | $216.29 | 2019 | |
| Kerecis Limited | $213.97 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Horizon Therapeutics Plc | $151.19 | 2021-2023 | Krystexxa |
| Biotissue Holdings INC. | $143.48 | 2023 | |
| Cook Medical LLC | $104.49 | 2019 | |
| Merck Sharp & Dohme LLC | $101.76 | 2019 | |
| Linvatec Corporation | $88.47 | 2023 | Colink 2, Colink Plating System |
| Kowa Pharmaceuticals America, INC. | $87.52 | 2022-2023 | Seglentis |
| Stryker Corporation | $39.05 | 2021-2025 | Dart-Fire |
| Treace Medical Concepts, INC. | $35.81 | 2022-2024 | |
| Melinta Therapeutics, LLC | $28.69 | 2019 | |
| Abbott Laboratories | $22.63 | 2024 | Eterna |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $20.25 | 2023 | Cmf |
| Depuy Synthes Sales INC. | $20.25 | 2019 | |
| Access Pro Medical, LLC | $19.81 | 2025 | Matriderm |
| Polynovo North America LLC | $19.48 | 2025 | Novosorb Btm |
| Hartmann USA, INC. | $16.61 | 2025 | Zetuvit Plus 10x10 P10 |
| Zimmer Biomet Holdings, INC. | $13.97 | 2021 | |
| Acell, INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Dzikowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.